Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease-Reference-Cited by-同舟云学术

Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease

Published:1995-08 Issue:2 Volume:109 Page:404-413
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

McLeod Robin S.,Wolff Bruce G.,Hillary Steinhart A.,Carryer Peter W.,O'Rourke Keith,Andrews David F.,Blair Joan E.,Cangemi John R.,Cohen Zane,Cullen James B.,Chaytor Robert G.,Greenberg Gordon R.,Jaffer Nasir M.,Jeejeebhoy Khursheed N.,MacCarty Robert L.,Ready Roger L.,Weiland Louis H.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference45 articles.

1. Inflammatory bowel disease;Thayer,1980

2. Recurrence and reoperation for Crohn's disease;Lock;N Engl J Med,1981

3. Prognosis after resection of chronic regional ileitis;Lennard Jones;Gut,1967

4. Crohn's disease in Stockholm county 1955–1974: a study of epidemiology;Hellers;Acta Chir Scand Suppl,1979

5. Crohn's disease: recurrence after surgical treatment;Nygaard;Scand J Gastroenterol,1977

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of the Eighth Scientific Workshop of ECCO: Prevention and Treatment of Postoperative Recurrence in Patients With Crohn’s Disease Undergoing an Ileocolonic Resection With Ileocolonic Anastomosis;Journal of Crohn's and Colitis;2023-04-18

2. Surgical Strategies to Reduce Postoperative Recurrence of Crohn's Disease After Ileocolic Resection;Frontiers in Surgery;2021-12-17

3. Does microscopic involvement of the surgical margins after ileocecectomy in Crohn’s patients predict early recurrence?;International Journal of Colorectal Disease;2021-04-29

4. Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews;Inflammatory Bowel Diseases;2021-01-16

5. The risk of later surgery at the anastomotic site following right hemicolectomy for Crohn's disease in a national cohort of 12 230 patients;Alimentary Pharmacology & Therapeutics;2020-10-21